Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis

NCT03669757 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis Vulgaris

Interventions

DRUG: LEO 134310
DRUG: LEO 134310
DRUG: LEO 134310
DRUG: LEO 134310
DRUG: LEO 134310 vehicle
DRUG: 0.1% betamethasone valerate ointment (class III steroid)

Sponsor

LEO Pharma